In obesity, the levels of inflammatory mediators increases, and the recruitment of immune cells through chemokine signalling pathways (including CCL2 and CCL5) contributes to the transition of inflammation into a chronic process [14]. This evidence concerns the gene CCL2 and obesity disorder.